PremiumCompany AnnouncementsUBS Group AG Acquires Significant Stake in Renalytix PLC UBS Reduces Stake in Renalytix Below 5% Threshold Renalytix Achieves Milestone with First Clinical Trial Use of KidneyIntelX PremiumCompany AnnouncementsUBS Group AG Acquires Significant Stake in Renalytix Renalytix’s KidneyIntelX Test Shows Significant Impact on Kidney Disease Treatment Renalytix Achieves Milestone with 20% Revenue Growth in Q3 PremiumCompany AnnouncementsUBS Group AG Acquires Major Stake in Renalytix PLC Renalytix AI Plc Reports Strong Half-Year Performance Renalytix Reports Strong Half-Year Progress and Strategic Expansion